Schumacher WA - Search Results

1

Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeys.

Schumacher WA, Heran CL, Goldenberg HJ, Harris DN, Ogletree ML. Schumacher WA, et al. Am J Physiol. 1989 Mar;256(3 Pt 2):H726-34. doi: 10.1152/ajpheart.1989.256.3.H726. Am J Physiol. 1989. PMID: 2522282

2

Antiplatelet activity of the long-acting thromboxane receptor antagonist BMS 180,291 in monkeys.

Schumacher WA, Steinbacher TE, Youssef S, Ogletree ML. Schumacher WA, et al. Prostaglandins. 1992 Nov;44(5):389-97. doi: 10.1016/0090-6980(92)90135-g. Prostaglandins. 1992. PMID: 1301074

3

Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.

Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM, et al. Harris DN, et al. Among authors: schumacher wa. J Pharmacol Exp Ther. 1992 Apr;261(1):131-7. J Pharmacol Exp Ther. 1992. PMID: 1532833

4

The combined antiischemic effects of the thromboxane receptor antagonist SQ 30,741 and tissue-type plasminogen activator.

Grover GJ, Parham CS, Schumacher WA. Grover GJ, et al. Among authors: schumacher wa. Am Heart J. 1991 Feb;121(2 Pt 1):426-33. doi: 10.1016/0002-8703(91)90708-p. Am Heart J. 1991. PMID: 1825008

5

The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.

Grover GJ, Parham CS, Schumacher WA. Grover GJ, et al. Among authors: schumacher wa. Basic Res Cardiol. 1991 Mar-Apr;86(2):99-106. doi: 10.1007/BF02190542. Basic Res Cardiol. 1991. PMID: 1831610

6

Thromboxane receptor activation during bronchospasm induced by platelet-activating factor.

Schumacher WA, Steinbacher TE. Schumacher WA, et al. J Lipid Mediat. 1991 Jul-Aug;4(1):97-110. J Lipid Mediat. 1991. PMID: 1832573

7

Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.

Schumacher WA, Heran CL, Hartl KS, Ogletree ML. Schumacher WA, et al. J Pharmacol Exp Ther. 1990 May;253(2):841-6. J Pharmacol Exp Ther. 1990. PMID: 2140131

8

Role of thromboxane receptor activation in the bronchospastic response to endothelin.

Schumacher WA, Steinbacher TE, Allen GT, Ogletree ML. Schumacher WA, et al. Prostaglandins. 1990 Jul;40(1):71-9. doi: 10.1016/0090-6980(90)90057-3. Prostaglandins. 1990. PMID: 2143841

9

Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.

Schumacher WA, Heran CL, Ogletree ML. Schumacher WA, et al. Eicosanoids. 1990;3(2):87-93. Eicosanoids. 1990. PMID: 2144979

10

The thromboxane receptor antagonist SQ 30,741 reduces myocardial infarct size in monkeys when given during reperfusion at a threshold dose for improving reflow during thrombolysis.

Schumacher WA, Grover GJ. Schumacher WA, et al. J Am Coll Cardiol. 1990 Mar 15;15(4):883-9. doi: 10.1016/0735-1097(90)90288-z. J Am Coll Cardiol. 1990. PMID: 2307799 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters